Page results
-
The Neurorehabilitation Unit (NRU) at The National Hospital for Neurology and Neurosurgery (NHNN) has been refurbished with funding from The National Brain Appeal to provide new facilities and additional space, transforming it into a more therapeutic environment.
-
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.
File results
-
UCLH Private maternity brochure May 2024
-
-
-
Maternity referral form
-
Headache Service additional medication Information
-
Psychology referral form (children and young patients)
-
RLHIM Pharmacy Product Catalogue
-
Patient telephone reminder service opt-out form
-
UCLH Membership Development Strategy
-
What young people would like everyone to know about Type 1 Diabetes